Professional Documents
Culture Documents
712
Definitions
Patients were defined as having bacterial meningitis if either of
the following 2 criteria were met: 1) the CSF culture was positive
for a bacterial pathogen; or 2) the presence of CSF pleocytosis (7
WBC per mm3)28 and either a positive blood culture or CSF latex
agglutination test positive for S pneumoniae, N meningitidis, H
influenzae, or Streptococcus agalactiae (group B Streptococcus). Patients in whom CSF culture revealed an organism usually associated with contamination (such as Staphylococcus epidermidis or
Propionobacterium acnes in previously healthy patients) were excluded.
Patients were categorized as having aseptic meningitis if they
had CSF pleocytosis with negative bacterial cultures as well as
negative CSF latex agglutination tests, if performed. Patients meeting this definition but who had been given systemic antibiotics
within 72 hours before lumbar puncture and blood culture (n
108) were not included in the analysis because the accuracy of
these pretreated cultures could not be assured and thus, we
could not be certain that these patients truly had aseptic meningitis.
Exclusion Criteria
To eliminate patients who would have required hospitalization
regardless of the risk of bacterial meningitis, the following criteria
were developed. We excluded patients who recently underwent
neurosurgical procedures (n 34), presented with clinical sepsis
or purpura fulminans (n 22), or were immunosuppressed (because of chemotherapy for oncologic diagnoses [n 5], who
underwent organ transplantation [n 3], had human immunodeficiency infection [n 4], or had primary immunodeficiencies [n
2]). We also excluded patients (n 10) who had other focal
bacterial infections requiring inpatient treatment that were recognized at the time of admission, including children younger than 3
Data Collection
We collected the following variables by a review of the computerized and/or written medical records and entered the information onto structured data sheets: date of birth, date of admission and discharge, gender, previous and present medical history
conditions, duration and peak of fever at admission, antibiotic
pretreatment, occurrence and timing of seizures, peripheral WBC
and differential, CSF WBC and differential, CSF red blood cell
count (RBC), CSF glucose, CSF protein, Gram stain, blood and CSF
cultures, and latex agglutination studies if performed. The presence of seizures was based on classification of the treating physician. The enteroviral season was defined as the time period between June 1 and October 31.29 The laboratory values obtained
closest in time to the lumbar puncture were used. When 2 CSF cell
counts were performed, the tube with fewest RBCs was used
regardless of the recorded tube number.
Statistical Methods
Univariate and multivariate analyses were conducted using the
Statistical Program for the Social Sciences.30 Confidence intervals
for proportions were calculated using Stata statistical software.31
Answer Tree statistical software was used to perform recursive
partitioning of the data.32
The database was randomly divided into a derivation set comprising two thirds of the patients and a validation set comprising
the remaining patients. The Student t test was used to compare
means between the derivation and validation sets and to identify
variables in the derivation set that were significantly associated
(P .05) with bacterial meningitis. To limit the number of variables considered, only those that were objective, biologically plausible, readily available at the time of hospital presentation, and
correlated with bacterial meningitis in previous studies were chosen. Because of the colinearity of some of these variables, we
selected peripheral ANC over WBC and CSF ANC over CSF WBC
based on inspection of the receiver operating characteristic (ROC)
curves of these variables against bacterial meningitis. To obtain a
simple and practical model, continuous predictors were dichotomized using rounded whole number values that allowed effective
discrimination between bacterial meningitis and aseptic meningitis. We selected these cutoffs by identifying predictor variable
values associated with a point of the ROC curve with the best
sensitivity-specificity trade off. These optimal cutoff points typically occur where the ROC curve turns the corner, at which
point each incremental gain in sensitivity results in a substantial
loss of specificity. We then rounded off these values for numerical
and clinical simplicity.
We then performed 2 multivariable statistical analyses on the
derivation set to identify significant predictors of bacterial meningitis. Only those patients with complete information on all candidate variables were considered in the multivariable analyses.
First, we entered the candidate variables as described above into a
forward stepwise multivariable logistic regression analysis. Variables independently associated (P .05) with bacterial meningitis
in this analysis were then ranked according to the magnitude of
the -coefficient.
Second, we performed binary recursive partitioning using the
candidate variables described above (ie, the same dichotomous
predictors used in the logistic regression analysis) using a classification tree algorithm32 to identify the most important predictors
of bacterial meningitis. As another form of multivariate analysis,
recursive partitioning may be superior to logistic regression when
the goal is to correctly classify patients with the outcome of
interest with the highest sensitivity rather than obtain overall
model accuracy. Recursive partitioning also explores interactions
between predictor variables natively in the algorithm. Finally, the
trees developed by the recursive partitioning software are easily
interpreted by investigators and clinicians alike and are well
suited for use in clinical decision-making.33,34 In the decision tree
development of the derivation set, we considered the same candidate variables as were considered in the logistic regression
analysis, and we then hand pruned the resultant tree for simplicity
and plausibility.
For ease of use in the clinical setting, we then created a Bacterial
Meningitis Score (BMS), using the predictor variables identified by
ARTICLES
Downloaded from pediatrics.aappublications.org at Indonesia:AAP Sponsored on May 12, 2015
713
RESULTS
Patient Characteristics
the derivation set were, on average, older at presentation and more likely to be male (Table 1). There
were no other statistically significant differences between the derivation and validation sets.
Univariate Analysis of the Derivation Set
Patients with bacterial meningitis were significantly more likely to be admitted in the nonenteroviral season and to have had seizures at or before
presentation than patients with aseptic meningitis.
Other variables commonly associated with bacterial
infection were also significantly different in patients
with bacterial compared with aseptic meningitis, including the peripheral ANC, CSF ANC, CSF glucose,
CSF protein, and positive Gram stain (Table 2).
Optimum cut offs for continuous variables were
then selected by analyzing the ROC curve for each
variable, as previously described (Fig 1). The following dichotomous variables were thus selected for
consideration in the multivariate analyses: admission
during nonenteroviral season, seizure at or before
presentation, peripheral ANC 10 000 cells/mm3,
CSF ANC 1000 cells/mm3, CSF glucose 35 mg/
dL, CSF protein 80 mg/dL, and positive Gram
stain.
Multivariate Analyses
Logistic Regression
Recursive partitioning was used to identify important predictors in the derivation set (Fig 2). The same
Derivation Set
( Standard Derivation)
N 456
Validation Set
( Standard Deviation)
N 240
5.0 (2.072.0)
281 (62%)
39.0 1.0
2.1 1.7
36 (8%)
291 (64%)
33 (7%)
4 (1%)
13.5 6.8
844 2759
53 19
89 137
64 (14%)
86 (19%)
3.0 (1.739.6)
126 (53%)
39.0 0.8
2.0 1.8
16 (7%)
154 (64%)
11 (5%)
0 (0%)
13.6 9.6
611 1501
55 19
75 74
31 (13%)
39 (16%)
* Means and their standard deviations are given for all continuous variables (with the exception of
age, which is presented as a median because of substantial skewness).
P .05.
714
TABLE 2.
Univariate Comparisons of Candidate Predictor Variables in the Derivation Set Between Patients With Bacterial and
Aseptic Meningitis*
Variable
Bacterial
Meningitis
N 86
22 (26%)
19 (22%)
14.2
2928
37
230
62 (72%)
Aseptic
Meningitis
N 370
Difference Between
Means or Proportions
(95% CI)
P Value
269 (73%)
14 (4%)
47% (3757)
18% (927)
.001
.001
6.0
8.2 (6.110.4)
.001
2820 (17203920)
19 (1226)
173 (20226)
72% (6281)
.001
.001
.001
.001
108
56
57
2 (0.5%)
* Means are given for continuous variables and proportions for categorical variables.
Fig 1. ROC curves for each of the continuous univariate candidate predictors: peripheral ANC, CSF ANC, CSF glucose, and CSF protein.
Arrow heads indicate the identified cut offs for dichotomization of the variables (see text). The 45 line through the origin represents the
ROC curve of a test whose decision ability is no better than chance.
TABLE 3.
Gram stain
CSF protein 80 mg/dL
Peripheral ANC 10 000 cells/mm3
Seizure at or before presentation
CSF ANC 1000 cells/mm3
P
Coefficient Value
5.6
2.2
2.0
1.8
1.7
95%
CI
.001 3.87.4
.001 1.03.4
.002 0.73.2
.03
0.23.4
.04 0.033.5
* Table gives the coefficient, P value, and odds ratio for each
independent predictor (P .05).
other predictors in the decision tree accurately discriminated bacterial from aseptic meningitis. At each
step of the decision tree, the risk of bacterial meningitis can be estimated for any particular combination
of predictor variables.
Prediction Model
ARTICLES
Downloaded from pediatrics.aappublications.org at Indonesia:AAP Sponsored on May 12, 2015
715
Fig 2. Results of the recursive partitioning analysis on the derivation set. Each box gives the number (and percentage) of patients with
bacterial and aseptic meningitis given the particular combination of predictor variables. Patients missing predictor variables have been
excluded (n 19).
Predictor
716
Points
Present
Absent
2
1
1
1
1
0
0
0
0
0
children with pneumococcal meningitis. When applied to the validation set, a BMS of 0 predicted
aseptic meningitis with 73% sensitivity (144/196,
95% CI: 67% 80%), 100% specificity (11/11, 95% CI:
72%100%), and positive predictive value of 100%
(144/144, 95% CI: 97%100%). A BMS 2 predicted
bacterial meningitis with 100% sensitivity (11/11,
95% CI: 72%100%), 97% specificity (191/196, 95%
CI: 94%99%), and 69% positive predictive value
(11/16, 95% CI: 41% 89%).
We performed a second subanalysis to evaluate
the performance of the prediction rule on patients
younger than 2 months old, because these children
are typically difficult to evaluate clinically and likely
have different risk of bacterial meningitis than older
patients. Of the 77 patients between 29 to 60 days of
age in the validation set, the prediction model accurately identified the 3 patients with bacterial meningitis.
DISCUSSION
Because accurately distinguishing bacterial meningitis from aseptic meningitis at the time of presentation is difficult, children with CSF pleocytosis are
routinely admitted to the hospital for treatment with
broad-spectrum antibiotics while awaiting results of
bacterial cultures. We have developed a scoring system based on multivariate logistic regression and
recursive partitioning analyses of data obtained from
hospitalized children with bacterial and aseptic meningitis. This prediction rule is based solely on data
that are objective and readily available at the time of
presentation. As shown by the performance of the
BMS on the validation set, this score accurately identifies patients both at high and very low risk of
bacterial meningitis.
Several findings of the current study are consistent
with prior investigations. We found Gram stain, seizure at or before presentation, peripheral ANC, CSF
ANC, and CSF protein to be significant univariate
predictors of bacterial meningitis, as shown in previous analyses.711,13,14 The considerable overlap of
these variables between the patients with aseptic and
bacterial meningitis, however, limits their discriminative ability when applied as univariate predictors.
Our study differs from previous studies in being
the first validated multivariate model derived from a
pediatric population in the postconjugate Hib vaccine era. As compared with the multivariate model
developed by Spanos and colleagues,27 our study
population comprises only children from an era in
which meningitis attributable to Hib has become
exceedingly rare because of widespread vaccination
(and indeed, no cases of Hib meningitis were found
in our population). In the model by Spanos, age was
a highly predictive variable, whereas the age of the
patient was not a significant predictor in our study.
This difference may reflect the fact that their study
included patients of all ages (1 month), whereas
our study included only pediatric patients (29
days18 years of age). Finally, although aseptic meningitis is more likely to occur in the enteroviral season, we did not find that time of the year provided
significant independent discriminative power with
ARTICLES
Downloaded from pediatrics.aappublications.org at Indonesia:AAP Sponsored on May 12, 2015
717
BMS must be interpreted with this in mind. In contrast, however, the sensitivity and specificity of our
scoring system are not affected by this potential bias.
Finally, several of the lumbar puncture results may
have been confounded by the presence of a high CSF
RBC (10 000 cells/mm3). From the outset of the
study, we chose not to attempt to apply any correction factor in these cases, as there is no routinely
accepted method to adjust for CSF WBC or protein in
the presence of elevated CSF RBC.39,40 We believe
that this decision did not adversely affect our results,
however, because the number of children in which
the CSF RBC was elevated was relatively low (n
23, 3% of all patients), but similar to other centers,13
and all of these patients had aseptic meningitis. This
would tend to bias against our model because of the
corresponding increase in CSF WBC and protein in
these children with aseptic meningitis who had elevated CSF RBC.
The epidemiology of bacterial meningitis in the
United States has been substantially transformed
over the past decade with the advent of universal
Hib immunization. The incidence of bacterial meningitis in children is likely to be reduced further over
the next few years as a consequence of pneumococcal
conjugate immunization. Nevertheless, because of
the multiple pathogens responsible for pediatric
meningitis,1 the possibility of pneumococcal serotype replacement41 43 and the realities of underimmunization44 and vaccine failures,45,46 a prediction
rule such as the BMS that identifies patients at very
low risk of bacterial meningitis and who may be
considered for outpatient therapy may be beneficial
to patients and result in important cost savings.
ACKNOWLEDGMENTS
We wish to acknowledge the support provided by a resident
research grant from the American Academy of Pediatrics (to Dr
Nigrovic) and a grant by the Meningitis Research Foundation (to
Dr Malley).
REFERENCES
1. Schuchat A, Robinson K, Wenger JD, et al. Bacterial meningitis in the
United States in 1995. N Engl J Med. 1997;337:970 976
2. Syriopoulou V, Daikos GL, Soulis K, et al. Epidemiology of invasive
childhood pneumococcal infections in Greece. Acta Paediatr Suppl. 2000;
89:30 34
3. Arditi M, Mason EO, Bradley JS, et al. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics
and outcome related to penicillin susceptibility and dexamethasone use.
Pediatrics. 1998;102:10871097
4. Stanek RJ, Mufson MA. A 20-year epidemiological study of pneumococcal meningitis. Clin Infect Dis. 1999;28:12651272
5. Malley R, Inkelis SH, Coelho P, Huskins WC, Kuppermann N. Cerebrospinal fluid pleocytosis and prognosis in invasive meningococcal
disease in children. Pediatr Infect Dis J. 1998;17:855 859
6. Wald ER, Kaplan SL, Mason EO, et al. Dexamethasone therapy for
children with bacterial meningitis. Pediatrics. 1995;95:2128
7. Marton KI, Gean AD. The spinal tap: a new look at an old test. Ann
Intern Med. 1986;104:840 848
8. Hristeva L, Bowler I, Booy R, King A, Wilkinson AR. Value of cerebrospinal fluid examination in the diagnosis of meningitis of the newborn.
Arch Dis Child. 1993;69:514 517
9. Sato Y, Ohta Y, Honda Y, Kaji M, Oizumi K. Diagnostic value of atypical
lymphocytes in cerebrospinal fluid from adults with enteroviral meningitis. J Neurol. 1998;245:598 602
10. Baker RC, Lenane AM. The predictive value of cerebrospinal fluid
differential cytology in meningitis. Pediatr Infect Dis J. 1989;8:329 330
718
11. Negrini B, Kelleher KJ, Wald ER. Cerebrospinal fluid findings in aseptic
versus bacterial meningitis. Pediatrics. 2000;105:316 319
12. Berkley JA, Mwangi I, Ngetsa CJ, et al. Diagnosis of acute bacterial
meningitis at a district hospital in sub-Saharan Africa. Lancet. 2001;357:
17531757
13. Freedman SB, Marrocco A, Pirie J, Dick PT. Predictors of bacterial
meningitis in the era after Haemophilus influenzae. Arch Pediatr Adolesc
Med. 2001;155:13011310
14. Dunbar SA, Eason RA, Musher DM, Clarridge JE. Microscopic examination and broth culture of cerebrospinal fluid in diagnosis of meningitis. J Clin Microbiol. 1998;36:16171620
15. Garty BZ, Berliner S, Liberman E, Danon YL. Cerebrospinal fluid leukocyte aggregation in meningitis. Pediatr Infect Dis J. 1997;16:647 651
16. Michelow I, Nicol M, Tiemessen C, Chezzi C, Pettifor J. Value of
cerebrospinal fluid leukocyte aggregation in distinguishing the cause of
meningitis in children. Pediatr Infect Dis J. 2000;19:66 72
17. Bailey EM, Domenico P, Cunha BA. Bacterial or viral meningitis? Measuring CSF lactate in CSF can help you know quickly. Postgrad Med.
1990;88:217223
18. Controni G, Rodriquez WJ, Hicks JM, et al. Cerebrospinal fluid lactic
acid levels in meningitis. J Pediatr. 1977;91:379 384
19. Leib SL, Bosacci R, Gratzl O, Zimmerli W. Predictive value of cerebrospinal fluid (CSF) lactate level versus CSF/blood glucose ratio for the
diagnosis of bacterial meningitis following neurosurgery. Clin Infect Dis.
1999;29:69 74
20. Schwarz S, Bertram M, Schwab S, Andrassy K, Hacke W. Serum procalcitonin levels in bacterial and abacterial meningitis. Crit Care Med.
2000;28:1828 1832
21. Gendrel D, Raymond J, Assicot M, et al. Measurement of procalcitonin
levels in children with bacterial or viral meningitis. Clin Infect Dis.
1997;24:1240 1242
22. Viallon A, Zeni F, Lambert C, et al. High sensitivity and specificity of
serum procalcitonin levels in adults with bacterial meningitis. Clin Infect
Dis. 1999;28:13131316
23. Hansson LO, Axelsson G, Linne T, Aurelius E, Lindquist L. Serum
C-reactive protein in the differential diagnosis of acute meningitis.
Scand J Infect Dis. 1993;25:625 630
24. Lembo RM, Marchant CD. Acute phase reactants and risk of bacterial
meningitis among febrile infants and children. Ann Emerg Med. 1991;
20:36 40
25. Dulkerian S, Kilpatrick L, Costarin AT, et al. Cytokine elevation in
infants with bacterial and aseptic meningitis. J Pediatr. 1995;126:872 876
26. Lo pez-Corte s LF, Marquez-Arbizu R, Jimenez-Jimenez LM, et al. Cerebrospinal fluid tumor necrosis factor-alpha, interleukin-1beta, interleukin-6 and interleukin-8 as diagnostic markers of cerebrospinal fluid
infection in neurosurgical patients. Crit Care Med. 2000;28:215219
27. Spanos A, Harrell FE Jr, Durack DT. Differential diagnosis of acute
meningitis: an analysis of the predictive value of initial observations.
JAMA. 1989;262:2700 2707
28. Barone MA. Laboratory values. In: McMillan JA, DeAngelis CD, Feigin
RD, Warshaw JD, eds. Oskis Pediatrics: Principles and Practice. 3rd ed.
New York, NY: Lippincott Williams & Wilkins; 1999:2225
29. Strikas RA, Anderson LJ, Parker RA. Temporal and geographic patterns
of isolates of nonpolio enteroviruses in the United States, 1970 1983.
J Infect Dis. 1986;153:346 351
30. SPSS for Windows. [computer program]. Version Release 7.5.2. Chicago,
IL: SPSS, Inc; 1997
31. Stata Statistical Software [computer program]. Version Release 6.0. College Station, TX: StataCorp; 1997
32. Answer Tree [computer program]. Version Release 2.0. Chicago, IL: SPSS
Inc; 1999
33. Brieman L, Friedman JH, Olshen RA, Stone CJ. Classification and Regression Trees. Washington, DC: Chapman & Hall; 1994
34. Stiell IG, Wells GA. Methologic standards for the development of clinical decision rules in emergency medicine. Ann Emerg Med. 1999;33:
437 447
35. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J. 2000;19:187195
36. Bradley JS, Ching DK, Phillips SE. Outpatient therapy of serious pediatric infections with ceftriaxone. Pediatr Infect Dis J. 1988;7:160 164
37. Congeni BL, Bradley JS, Hammerschlag MR. Safety and efficacy of once
daily ceftriaxone for the treatment of bacterial meningitis. Pediatr Infect
Dis J. 1986;5:293297
38. Laupacis A, Sekar N, Stiell I. Clinical prediction rules: a review and
suggested modifications of methodological standards. JAMA. 1997;277:
488 494
39. Bonadio WA, Smith DS, Goddard S, Burroughs J, Khaja C. Distinguishing cerebrospinal fluid abnormalities in children with bacterial meningitis and traumatic lumbar punctures. J Infect Dis. 1990;162:251254
40. Bonadio WA. The cerebrospinal fluid: physiologic aspects and alterations associated with bacterial meningitis. Pediatr Infect Dis J. 1992;11:
423 431
41. Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate
vaccine against acute otitis media. N Engl J Med. 2001;344:403 409
42. Lipsitch M. Bacterial vaccines and serotype replacement: lessons from
Haemophilus influenzae and prospects for Streptococcus pneumoniae. Emerg
Infect Dis. 1999;5:336 345
43. Lipsitch M. Interpreting results from trials of pneumococcal conju-
gate vaccines: a statistical test for detecting vaccine-induced increases in carriage of nonvaccine serotypes. Am J Epidemiol. 2001;154:
8592
44. National, state and urban area vaccination coverage levels among children aged 19 35 monthsUnited States, July 1994 June 1995. MMWR
Morb Mortal Wkly Rep. 1996;45:508 513
45. Breukels MA, Spanjaard L, Sanders LA, Rijkers GT. Immunological
characterization of conjugated Haemophilus influenzae type b vaccine
failure in infants. Clin Infect Dis. 2001;32:1700 1705
46. Heath PT, Booy R, Azzopardi H, et al. Antibody concentration and
clinical protection after Hib conjugate vaccination in the United Kingdom. JAMA. 2000;284:2334 2340
. . . In Florida . . . the State Legislature unanimously passed a bill last week that
extends to people who have seizure disorders the right to be accompanied in public
places by a trained service dog. . . Florida may be the first state to pass such a
measure. . . A study of patients and their seizure-alert dogs by the University of
Floridas Epilepsy Clinic in 1998 determined that some dogs do detect seizures, but
the scientists did not have the money to investigate whether early detection was a
spontaneous reaction or trainable behavior. . . One nonprofit agency that trains the
dogs, Canine Assistants, Inc. of Alpharetta, Georgia, says it has placed 17 Golden
and Labrador Retrievers with epileptic owners in 7 years, expects to place 10 this
year alone and has a waiting list for 60 dogs.
Noted by JFL, MD
ARTICLES
Downloaded from pediatrics.aappublications.org at Indonesia:AAP Sponsored on May 12, 2015
719
References
Citations
Subspecialty Collections
Reprints
The online version of this article, along with updated information and services, is
located on the World Wide Web at:
http://pediatrics.aappublications.org/content/110/4/712.full.html